We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

59 hedge funds and large institutions have $46.1M invested in Actinium Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

117% more capital invested

Capital invested by funds: $21.2M → $46.1M (+$24.9M)

38% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 8

6.2% more ownership

Funds ownership: 11.42% → 17.62% (+6.2%)

5% more funds holding

Funds holding: 56 → 59 (+3)

17% less call options, than puts

Call options by funds: $3.46M | Put options by funds: $4.18M

Holders
59
Holders Change
+3
Holders Change %
+5.36%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
25
Reduced
9
Closed
8
Calls
$3.46M
Puts
$4.18M
Net Calls
-$712K
Net Calls Change
-$1.93M

Top Buyers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.43M
2
BlackRock
BlackRock
New York
+$2.33M
3
Two Sigma Investments
Two Sigma Investments
New York
+$2M
4
EI
EAM Investors
California
+$2M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$1.98M

Top Sellers

Rank Fund Capital Flow
1
Group One Trading
Group One Trading
Illinois
-$713K
2
JGC
J. Goldman & Co
New York
-$696K
3
Simplex Trading
Simplex Trading
Illinois
-$347K
4
Franklin Resources
Franklin Resources
California
-$153K
5
William Blair & Company
William Blair & Company
Illinois
-$148K
Name Holding Trade Value Shares
Change 		Change in
Stake
SL
26
Sentinus LLC
Illinois
$272K +$5.07K +500 +2%
JF
27
Jump Financial
Illinois
$253K +$3.18K +313 +1%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$239K -$6.93K -683 -3%
Marshall Wace
29
Marshall Wace
United Kingdom
$239K +$228K +22,459 New
IFPG
30
Intrepid Financial Planning Group
Indiana
$213K – – –
Bank of America
31
Bank of America
North Carolina
$213K +$1.49K +147 +0.7%
Jane Street
32
Jane Street
New York
$207K +$198K +19,462 New
6CM
33
683 Capital Management
New York
$177K +$169K +16,629 New
Rockefeller Capital Management
34
Rockefeller Capital Management
New York
$160K +$7.61K +750 +5%
Man Group
35
Man Group
United Kingdom
$137K +$131K +12,901 New
PCM
36
Perritt Capital Management
Illinois
$128K – – –
Goldman Sachs
37
Goldman Sachs
New York
$107K +$355 +35 +0.3%
Simplex Trading
38
Simplex Trading
Illinois
$60K -$347K -34,198 -86%
Wells Fargo
39
Wells Fargo
California
$58.3K +$4.11K +405 +8%
UBS Group
40
UBS Group
Switzerland
$34.5K +$14.2K +1,399 +76%
Osaic Holdings
41
Osaic Holdings
Arizona
$33K +$2.03K +200 +7%
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$29K +$26.4K +2,606 +4,572%
CG
43
Cutler Group
California
$25K -$7.3K -719 -23%
Group One Trading
44
Group One Trading
Illinois
$21.4K -$713K -70,244 -97%
FDCDDQ
45
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.8K – – –
ASN
46
Advisory Services Network
Georgia
$10.7K +$10.1K +1,000 New
National Bank of Canada
47
National Bank of Canada
Quebec, Canada
$9.03K – – –
FWA
48
Freedom Wealth Alliance
Wisconsin
$7.49K +$7.13K +703 New
HFM
49
Hartford Financial Management
Connecticut
$6.37K – – –
TRCT
50
Tower Research Capital (TRC)
New York
$5K -$41.9K -4,129 -90%
1
2
3

ATNM Hedge Fund Activity: Q4 2022 in Review

59 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q4 2022, worth a combined $46.1M — up 117% from $21.2M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ATNM positions and 8 closed out — a net gain of 3 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $2.43M. The largest seller was Group One Trading, cutting an estimated $713K.

  • 59 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q4 2022, up from 56 in Q3 2022.
  • Funds reported $46.1M of Actinium Pharmaceuticals stock for Q4 2022, up 117% quarter-over-quarter.
  • 11 funds opened new Actinium Pharmaceuticals positions in Q4 2022 and 8 closed out, a net change of +3 holders.
  • The largest Actinium Pharmaceuticals buyer in Q4 2022 was D.E. Shaw & Co, an estimated $2.43M added.
  • The largest Actinium Pharmaceuticals seller in Q4 2022 was Group One Trading, an estimated $713K sold.

Based on aggregated 13F filings for Q4 2022.